Altamira Therapeutics Ltd. Noncurrent Assets
Altamira Therapeutics Ltd. (CYTOF) had Noncurrent Assets of $6.88 million as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:NoncurrentAssets · last filed 2025-08-29
- 2023-12-31: Noncurrent Assets 6.47M CHF.
- 2023-06-30: Noncurrent Assets 4.47M CHF.
- 2022-12-31: Noncurrent Assets 4.53M CHF.
- 2022-06-30: Noncurrent Assets 16.55M CHF.
CHF
| Period end | Noncurrent Assets |
|---|---|
| 2023-12-31 | 6.47M CHF 20-F/A · filed 2024-04-22 |
| 2023-06-30 | 4.47M CHF 6-K · filed 2023-09-12 |
| 2022-12-31 | 4.53M CHF 20-F/A · filed 2024-04-22 |
| 2022-06-30 | 16.55M CHF 6-K/A · filed 2023-08-21 |
| 2021-12-31 | 15.08M CHF 6-K/A · filed 2023-08-21 |
| 2021-06-30 | 14.59M CHF 6-K · filed 2021-09-08 |
| 2020-12-31 | 9.18M CHF 20-F · filed 2022-04-12 |
| 2020-06-30 | 7.57M CHF 6-K/A · filed 2020-09-17 |
| 2019-12-31 | 6.85M CHF 20-F · filed 2021-03-31 |
| 2019-06-30 | 5.42M CHF 6-K · filed 2019-08-15 |
| 2018-12-31 | 3.81M CHF 20-F · filed 2020-04-16 |
| 2017-12-31 | 1.96M CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 1.97M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Noncurrent Assets |
|---|---|
| 2025-06-30 | $6.88M 6-K · filed 2025-08-29 |
| 2024-12-31 | $7.11M 6-K · filed 2025-08-29 |
| 2024-06-30 | $7.55M 6-K · filed 2024-09-24 |
| 2023-12-31 | $7.69M 20-F · filed 2025-04-30 |
| 2023-01-01 | $4.90M 20-F · filed 2025-04-30 |